XML 107 R61.htm IDEA: XBRL DOCUMENT v3.25.1
Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2023 (Details)
€ / shares in Units, $ / shares in Units, € in Thousands, $ in Millions
1 Months Ended 6 Months Ended 12 Months Ended 18 Months Ended 121 Months Ended
Nov. 02, 2023
EUR (€)
Oct. 24, 2023
EUR (€)
€ / shares
shares
Oct. 24, 2023
USD ($)
shares
Aug. 24, 2023
EUR (€)
Aug. 22, 2023
EUR (€)
Aug. 21, 2023
EUR (€)
Aug. 20, 2023
EUR (€)
transaction
€ / shares
May 24, 2023
€ / shares
shares
Feb. 22, 2023
EUR (€)
€ / shares
shares
Sep. 07, 2022
EUR (€)
€ / shares
shares
Sep. 02, 2022
EUR (€)
transaction
€ / shares
shares
Jul. 30, 2021
EUR (€)
€ / shares
shares
Oct. 31, 2020
shares
Dec. 31, 2023
shares
plan
€ / shares
Dec. 31, 2024
EUR (€)
shares
€ / shares
Dec. 31, 2023
EUR (€)
€ / shares
shares
Dec. 31, 2022
EUR (€)
€ / shares
shares
Dec. 31, 2024
shares
€ / shares
Dec. 31, 2023
EUR (€)
€ / shares
Nov. 19, 2024
€ / shares
Oct. 24, 2023
$ / shares
Disclosure of detailed information about borrowings [line items]                                          
Capital increase from issuance of ordinary shares                 € 130,000 € 46,231           € 353,377 € 46,231        
Capital increase from issuance of ordinary shares (in shares) | shares   20,325,500 20,325,500           20,000,000 5,530,000           40,325,500 5,530,000        
Par value per share (in euro per share) | € / shares   € 0.01           € 0.01 € 0.01 € 0.01       € 0.01 € 0.01 € 0.01 € 0.01 € 0.01 € 0.01 € 0.01  
Equity issuance, subscripion price per share (in euro per share) | € / shares                 € 6.50 € 8.36                      
Share issue related cost                               € 28,111 € 3,280        
Exercises of share warrants (in shares) | shares                         464,309   4,000   19,134        
Proceeds from borrowings                                     € 175,000    
Repayments of convertible loan notes       € 33,000                     € 8,750 27,188 € 0        
Capital increases   € 223,300 $ 235.8                       € 0 353,377 46,231   € 557,200    
Capital increases   202,000 212.2                                    
Payments for share issue costs   € 21,300 $ 23.6                                    
Free Shares (AGA)                                          
Disclosure of detailed information about borrowings [line items]                                          
Number of share-based compensation plans issued | plan                           5              
Number of instruments issued (in shares) | shares                           2,601,296 1,946,125     4,547,421      
ADS                                          
Disclosure of detailed information about borrowings [line items]                                          
Capital increase from issuance of ordinary shares (in shares) | shares   18,699,460 18,699,460                                    
Number of shares received per ADS (in shares) | shares   1 1                                    
Issue of equity, offering price per share (in dollar/euro per share) | $ / shares                                         $ 11.60
Ordinary shares                                          
Disclosure of detailed information about borrowings [line items]                                          
Capital increase from issuance of ordinary shares (in shares) | shares   1,626,040 1,626,040                                    
Issue of equity, offering price per share (in dollar/euro per share) | € / shares   € 10.9864                                      
Kreos 1, convertible bond loans, tranche A                                          
Disclosure of detailed information about borrowings [line items]                                          
Number of other share warrants repurchased (in shares) | shares               43,070                          
Exercises of share warrants (in shares) | shares               67,887                          
Kreos 1, convertible bond loans, tranche B                                          
Disclosure of detailed information about borrowings [line items]                                          
Number of other share warrants repurchased (in shares) | shares               43,070                          
Exercises of share warrants (in shares) | shares               31,696                          
Repayments of convertible loan notes       8,000   € 7,661                              
Kreos & Claret financing                                          
Disclosure of detailed information about borrowings [line items]                                          
Borrowings, maximum borrowing capacity             € 75,000                            
Aggregate exercise price       4,000                                  
Kreos & Claret financing | Kreos C BSA                                          
Disclosure of detailed information about borrowings [line items]                                          
Issuance of other share warrants € 4,000                                        
Kreos & Claret financing | Maximum                                          
Disclosure of detailed information about borrowings [line items]                                          
Aggregate exercise price             € 8,000                            
Heights convertible notes                                          
Disclosure of detailed information about borrowings [line items]                                          
Equity issuance, subscripion price per share (in euro per share) | € / shares             € 14.4303                            
Borrowings, maximum borrowing capacity             € 75,000                            
Proceeds from borrowings       35,000                                  
Heights convertible notes | Maximum                                          
Disclosure of detailed information about borrowings [line items]                                          
Equity issuance, subscripion price per share (in euro per share) | € / shares             € 14.4303                            
Kreos / Claret convertible notes (OCABSA)                                          
Disclosure of detailed information about borrowings [line items]                                          
Proceeds from borrowings         € 25,000                                
Oceane                                          
Disclosure of detailed information about borrowings [line items]                                          
Capital increase from issuance of ordinary shares (in shares) | shares                       1,964,031                  
Equity issuance, subscripion price per share (in euro per share) | € / shares                       € 30.55                  
Repayments of convertible loan notes       25,102                       25,000          
Capital increases                       € 60,000                  
Kreos & Claret financing and Heights convertible notes                                          
Disclosure of detailed information about borrowings [line items]                                          
Proceeds from borrowings, net of refinancing of existing indebteness       € 27,000                                  
Share premium                                          
Disclosure of detailed information about borrowings [line items]                                          
Capital increase from issuance of ordinary shares                               € 352,974 € 46,176        
€130.0 million cross-over financing, february 2023                                          
Disclosure of detailed information about borrowings [line items]                                          
Financial agreement, amount                 € 130,000                        
Capital increase from issuance of ordinary shares                 € 130,000                        
Capital increase from issuance of ordinary shares (in shares) | shares                 20,000,000                        
Par value per share (in euro per share) | € / shares                 € 0.01                        
Equity issuance, subscripion price per share (in euro per share) | € / shares                 € 6.50                        
€130.0 million cross-over financing, february 2023 | Share premium                                          
Disclosure of detailed information about borrowings [line items]                                          
Share issue related cost                 € 6,700                        
€49.2 million cross-over financing, september 2022                                          
Disclosure of detailed information about borrowings [line items]                                          
Financial agreement, amount                     € 49,200                    
Capital increase from issuance of ordinary shares (in shares) | shares                     5,530,000                    
Par value per share (in euro per share) | € / shares                     € 0.01                    
Equity issuance, percentage of current share capital                 89.60%   33.00%                    
Equity issuance, subscripion price per share (in euro per share) | € / shares                     € 8.36                    
Financial agreement, number of transactions | transaction                     2                    
Capital increases                     € 46,200                    
€49.2 million cross-over financing, september 2022 | Share premium                                          
Disclosure of detailed information about borrowings [line items]                                          
Share issue related cost                     € 3,300                    
€150.0 million financing, august 2023                                          
Disclosure of detailed information about borrowings [line items]                                          
Financial agreement, amount             € 150,000                            
Financial agreement, number of transactions | transaction             2